SeedCue
News
Exergy3 has raised £10 million in seed funding to scale its proprietary technology addressing three of Europe’s most pressing challenges: industrial decarbonisation, grid balancing and energy security.
Eka VC announced the final close of its second fund at $107 million (£80 million). This milestone cements Eka’s position as the UK’s largest early-stage impact investor focused on the intersection of health, wellbeing, and sustainability.
Featured
Explore more
News
Emerald Technology Ventures, a globally recognized venture capital firm with two decades of water-sector leadership, announced reaching the €100 million milestone for its Global Water Fund II.
Amatera, a Paris-based biotechnology company, announced the closing of its latest funding round of €6 million in equity. The round was co-led by Demea Sustainable Investment (ex-Demeter) and Oyster Bay Venture Capital, with participation from existing investors - PINC, Mudcake, and Exceptional Ventures.
German-based healthtech company Oska Health announced an €11 million seed funding round, led by Capricorn Partners and SwissHealth Ventures.
nyra Health, developer of an AI-powered platform for neurological therapy, has successfully closed a €20 million Series A funding round.
The Gates Foundation has awarded a $5 million grant to Axmed, a Swiss health-tech startup modernizing how essential medicines are procured across emerging markets.
Lifeaz, a startup based in France that aims to make defibrillators more widely available to households and organizations, has raised €13 million.
Sable Bio, a London-based AI startup focused on drug safety, has raised $3.75 million in seed funding to scale its platform that helps pharmaceutical companies identify safety risks earlier in drug discovery.
